MedPath

Study of Portulaca Oleracea and Cumin effects on serum paraoxanase 1 activity

Phase 2
Conditions
Metabolic disorders.
Disorders of lipoprotein metabolism and other lipidaemias
Registration Number
IRCT138902063806N1
Lead Sponsor
Shahrekord university of medical sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
90
Inclusion Criteria

patients with low density lipoprotein cholesterol (LDL-C) over than 120 mg/dl. Exclusion criteria: patients with metabolic disease such as diabetes mellitus, renal diseases and individuals taking lipid lowering or anti hypertension drug.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Paraxonase1. Timepoint: before and after 45 days of intervention. Method of measurement: blood sample.
Secondary Outcome Measures
NameTimeMethod
Apo A1. Timepoint: before and after 45 days of intervention. Method of measurement: blood sample.;Apo B. Timepoint: before and after 45 days of intervention. Method of measurement: blood sample.;Cholesterol. Timepoint: before and after 45 days of intervention. Method of measurement: blood sample.;Triglyceride. Timepoint: before and after 45 days of intervention. Method of measurement: blood sample.;HDL. Timepoint: before and after 45 days of intervention. Method of measurement: blood sample.;LDL. Timepoint: before and after 45 days of intervention. Method of measurement: blood sample.;OX LDL. Timepoint: before and after 45 days of intervention. Method of measurement: blood sample.
© Copyright 2025. All Rights Reserved by MedPath